| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
ALB
|
albumin
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALPP
|
alkaline phosphatase, placental
|
|
AMOT
|
angiomotin
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL6
|
angiopoietin-like 6
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APOC2
|
apolipoprotein C-II
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
BAIAP2
|
BAI1-associated protein 2
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMPER
|
BMP binding endothelial regulator
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BSG
|
basigin (Ok blood group)
|
|
BTC
|
betacellulin
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN10
|
calpain 10
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCK
|
cholecystokinin
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD163
|
CD163 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD69
|
CD69 molecule
|
|
CD70
|
CD70 molecule
|
|
CD81
|
CD81 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR3
|
complement factor H-related 3
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHGA
|
chromogranin A
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLASP2
|
cytoplasmic linker associated protein 2
|
|
CLDN1
|
claudin 1
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DEFA1B
|
defensin, alpha 1B
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DNM1
|
dynamin 1
|
|
DNMBP
|
dynamin binding protein
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DSG3
|
desmoglein 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EEA1
|
early endosome antigen 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
ENAM
|
enamelin
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FBN1
|
fibrillin 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOXP3
|
forkhead box P3
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FXN
|
frataxin
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GATA6
|
GATA binding protein 6
|
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GFM1
|
G elongation factor, mitochondrial 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNPTG
|
N-acetylglucosamine-1-phosphate transferase, gamma subunit
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GRN
|
granulin
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIRA
|
histone cell cycle regulator
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB2
|
high mobility group box 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTOR
|
5-hydroxytryptamine (serotonin) oxygenase regulator
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL24
|
interleukin 24
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
INADL
|
InaD-like (Drosophila)
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB6
|
integrin, beta 6
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KEL
|
Kell blood group, metallo-endopeptidase
|
|
KIF22
|
kinesin family member 22
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LALBA
|
lactalbumin, alpha-
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIMA1
|
LIM domain and actin binding 1
|
|
LIMK1
|
LIM domain kinase 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LTA
|
lymphotoxin alpha
|
|
LYZ
|
lysozyme
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MGP
|
matrix Gla protein
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR126
|
microRNA 126
|
|
MIR137
|
microRNA 137
|
|
MIR142
|
microRNA 142
|
|
MIR195
|
microRNA 195
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR494
|
microRNA 494
|
|
MIR612
|
microRNA 612
|
|
MIRLET7B
|
microRNA let-7b
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOV10
|
Mov10 RISC complex RNA helicase
|
|
MPO
|
myeloperoxidase
|
|
MPRIP
|
myosin phosphatase Rho interacting protein
|
|
MPZ
|
myelin protein zero
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO10
|
myosin X
|
|
MYRIP
|
myosin VIIA and Rab interacting protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME4
|
NME/NM23 nucleoside diphosphate kinase 4
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOLC1
|
nucleolar and coiled-body phosphoprotein 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPY
|
neuropeptide Y
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRP1
|
neuropilin 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE10A
|
phosphodiesterase 10A
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE8A
|
phosphodiesterase 8A
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PEPD
|
peptidase D
|
|
PGF
|
placental growth factor
|
|
PGLYRP2
|
peptidoglycan recognition protein 2
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD2
|
phospholipase D2
|
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6
|
|
PLP1
|
proteolipid protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
POLI
|
polymerase (DNA directed) iota
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRTN3
|
proteinase 3
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4P3
|
prostaglandin E receptor 4 (subtype EP4) pseudogene 3
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTX3
|
pentraxin 3, long
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAD51
|
RAD51 recombinase
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCAN1
|
regulator of calcineurin 1
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RHOA
|
ras homolog family member A
|
|
RHOD
|
ras homolog family member D
|
|
RLN1
|
relaxin 1
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF6
|
ring finger protein (C3H2C3 type) 6
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SAA2
|
serum amyloid A2
|
|
SASS6
|
spindle assembly 6 homolog (C. elegans)
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB3A2
|
secretoglobin, family 3A, member 2
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGPL1
|
sphingosine-1-phosphate lyase 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPEN
|
spen family transcriptional repressor
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR3
|
small proline-rich protein 3
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STX4
|
syntaxin 4
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TARDBP
|
TAR DNA binding protein
|
|
TEC
|
tec protein tyrosine kinase
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM43
|
transmembrane protein 43
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TRA
|
T cell receptor alpha locus
|
|
TRB
|
T cell receptor beta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSFM
|
Ts translation elongation factor, mitochondrial
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UCN
|
urocortin
|
|
UCN3
|
urocortin 3
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
|
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T)
|
|
VCAN
|
versican
|
|
VDAC2
|
voltage-dependent anion channel 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VRK1
|
vaccinia related kinase 1
|
|
VRK2
|
vaccinia related kinase 2
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWF
|
von Willebrand factor
|
|
WASF2
|
WAS protein family, member 2
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
XPO1
|
exportin 1
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YBX1
|
Y box binding protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|